The risk for acquiring prostate cancer in men is as high as breast cancer in women; different treatments available

Men developing prostate cancer are as high as breast cancer in women.

Men developing prostate cancer are as high as breast cancer in women.

According to the American Cancer Society,  1 in 7 men is prone to be diagnosed with prostate cancer, with a prostate cancer mortality rate of 1 in 38 men.

A prostate cancer diagnosis is not an instant death sentence. Prostate cancer is treatable  in many ways.

The most common treatment is surgery. In surgery, the prostate along with some its tissue is removed. Patients will be inserted with a catheter, which will remain there for two weeks or more, taking  up to five weeks before the patient can do normal activities.

Another treatment option is radiation therapy for people who wishes to sidestep surgery. Side effects include difficulty in urinating or expelling the bowels.

Hormone therapy is a another treatment used for recurring prostate cancer after surgery or radiation therapy. With this treatment, the hormones testosterone and dihydrotestosterone is reduced. This is done by surgical castration or a through medication.

A new treatment option is gene therapy. A  written study by Dr. Paul B. Fisher Oncotarget journal gives a detailed account of how gene therapy is used to treat prostate cancer.

Men 50-years-old and older should be screened for prostate cancer yearly. If you have family history, or you experience difficulty in  urinating, 40-years-old and up  should be regularly screened for prostate cancer.





Leave a Reply

Your email address will not be published. Required fields are marked *